Bioactive small molecules in calcium phosphate scaffold enhanced osteogenic differentiation of human induced pluripotent stem cells

Dent Mater J. 2021 May 29;40(3):615-624. doi: 10.4012/dmj.2019-263. Epub 2021 May 3.

Abstract

Human induced pluripotent stem cells (hiPSCs) are exciting for regenerative medicine due to their multi-potent differentiation. SB431542 bioactive molecule can activate bone morphogenetic protein-signalling in osteoblasts. The objectives were to: (1) develop a novel injectable calcium phosphate cement (CPC)-SB431542 scaffold for dental/craniofacial bone engineering; and (2) investigate cell proliferation and osteo-differentiation of hiPSC-derived mesenchymal stem cells (hiPSC-MSCs) on CPC-SB431542 scaffold. Three groups were tested: CPC control; CPC with SB431542 inside CPC (CPCSM); CPC with SB431542 in osteogenic medium (CPC+SMM). SB431542 in CPC promoted stem cell proliferation and viability. hiPSC-MSCs differentiated into osteogenic lineage and synthesized bone minerals. CPC with SB431542 showed much greater osteo-expressions and more bone minerals than those without SB431542. In conclusion, hiPSC-MSCs on CPC scaffold containing SB431542 showed excellent osteo-differentiation and bone mineral synthesis for the first time. CPC was a suitable scaffold for delivering stem cells and SB431542 to promote bone regeneration in dental/craniofacial applications.

Keywords: Bone tissue engineering; Calcium phosphate cement; Induced-pluripotent stem cells; Osteogenic differentiation; Small molecule SB431542.

MeSH terms

  • Bone Cements
  • Calcium Phosphates / pharmacology
  • Cell Differentiation
  • Cells, Cultured
  • Humans
  • Induced Pluripotent Stem Cells*
  • Osteogenesis*
  • Tissue Engineering
  • Tissue Scaffolds

Substances

  • Bone Cements
  • Calcium Phosphates